Bank of America earnings beat Street forecasts, but bond losses jump amid Treasury rout
Updated at 7:50 am EDT Bank of America (BAC) - Get Free Report posted better-than-expected third quarter earnings Tuesday, thanks to solid gains in net interest income from its lending business, but noted a big jump in unrealized losses in its bond portfolio. Bank of America said earnings for the three months ending in September came in at 90 cents per share, up 11.1% from the same period last year 8 cents ahead of the Street consensus forecast. Group revenues, Bank of America said, were 2% higher than last year at $25.2 billion once interest expenses were stripped out, a tally that largely matched analysts' forecasts. Net interest income, a key measure of bank profitability, rose 4% to $14.4 billion, the bank said, while investment banking fees, Bank of America said, rose 2% to $1.2 billion. Consumer banking revenues, by far the larger portion of the lender's top line, rose 6% to $10.5 billion, while its overall deposit base was pegged at $9.1 trillion. Another key figure for the bank was the unrealized losses in its bond portfolio, which jumped 24% from the second quarter to $131.6 billion amid the surge in Treasury yields β which pushed market prices lower β over the final two months of the quarter. βOur teammates delivered another strong quarter. We generated $7.8 billion in earnings, up 10 percent from the third quarter a year ago. We added clients and accounts across all lines of business," said CEO Brian Moynihan. "We did this in a healthy but slowing economy that saw US consumer spending still ahead of last year but continuing to slow," he added. "Our growth in revenue and earnings allowed us to continue our investments in our people and technology to drive an enhanced client experience.β Bank of America shares were marked 0.7% higher in pre-market trading immediately following the earnings release to indicate an opening bell price of $27.18 each.Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...
Updated at 7:50 am EDT Bank of America (BAC) - Get Free Report posted better-than-expected third quarter earnings Tuesday, thanks to solid gains in net interest income from its lending business, but noted a big jump in unrealized losses in its bond portfolio. Bank of America said earnings for the three months ending in September came in at 90 cents per share, up 11.1% from the same period last year 8 cents ahead of the Street consensus forecast. Group revenues, Bank of America said, were 2% higher than last year at $25.2 billion once interest expenses were stripped out, a tally that largely matched analysts' forecasts. Net interest income, a key measure of bank profitability, rose 4% to $14.4 billion, the bank said, while investment banking fees, Bank of America said, rose 2% to $1.2 billion. Consumer banking revenues, by far the larger portion of the lender's top line, rose 6% to $10.5 billion, while its overall deposit base was pegged at $9.1 trillion. Another key figure for the bank was the unrealized losses in its bond portfolio, which jumped 24% from the second quarter to $131.6 billion amid the surge in Treasury yields β which pushed market prices lower β over the final two months of the quarter. βOur teammates delivered another strong quarter. We generated $7.8 billion in earnings, up 10 percent from the third quarter a year ago. We added clients and accounts across all lines of business," said CEO Brian Moynihan. "We did this in a healthy but slowing economy that saw US consumer spending still ahead of last year but continuing to slow," he added. "Our growth in revenue and earnings allowed us to continue our investments in our people and technology to drive an enhanced client experience.β Bank of America shares were marked 0.7% higher in pre-market trading immediately following the earnings release to indicate an opening bell price of $27.18 each.Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...
TheStreet
Bank of America earnings beat Street forecasts, but bond losses jump amid Treasury rout
Big gains in net interest income powered solid third quarter earnings for Bank of America, but investors are likely to focus on unrealized losses in its bond portfolio and Treasury yields continue to rise.
*Financial stocks have slumped; here are 10 with potential*
The S&P 500 Financials stock index produced a negative 3.11% return so far this year through Friday, compared with a 13% gain for the S&P 500 as a whole. But 17 financial services stocks made Morningstarβs list of the best stocks to own for 2023. The companies on that list all have wide Morningstar moat ratings. That means the firm sees them having competitive advantages that will last at least 20 years. Morningstar also says the companies have strong management teams, balance sheets and investments. Here are 10 of the companies on the financial services roster, listed alphabetically.Credit Cards, Investments, Financial Exchange 1. American Express (AXP) - Get Free Report, the upscale credit card company Morningstar fair value estimate: $178. Monday price quote: $153.05. βThe companyβs greatest strength remains its cardholder base of high-spending individuals and small businesses,β wrote Morningstar analyst Michael Miller. βThe high average spending rate on American Express cards makes its cardholders attractive to merchants, and the company has been able to form valuable partnerships in exchange for access to these cardholders.β Miller sees this trend continuing.Related: Morningstar just named 3 top 'dividend aristocrat' stocks 2. Berkshire Hathaway (BRK.B) - Get Free Report, Warren Buffettβs investment group Morningstar fair value estimate: $400. Monday price quote: $347.15. βBerkshire, owing to its diversification and its lower overall risk profile, offers one of the better risk-adjusted return profiles in the financial-services sector,β wrote Morningstar analyst Greggory Warren. βAnd it remains a generally solid candidate for downside protection during market selloffs.β In addition, βit will take some time before the firm finally succumbs to the impediments created by the sheer size and scale of its operations,β he said. Warren Buffett's Berkshire Hathaway investment group is on Morningstar's list of best financial-services stocks. shutterstock 3. CME (CME) - Get Free Report, the financial-exchange operator Morningstar fair value estimate: $215. Monday price quote: $219.25. βCME has a dominant position in many of the contracts that trade in its exchange and is well diversified across multiple product lines,β Miller wrote. βIn the long term, we anticipate that the company will continue to benefit from secular growth in the need to hedge commodity, energy, and interest rate exposure. CME also has a history of generating incremental growth through the introduction of new futures contracts.β 4. JPMorgan Chase (JPM) - Get Free Report, the financial-services group Morningstar fair value estimate: $153. Monday price quote: $147.55. 5. Northern Trust (NTRS) - Get Free Report, a trust bank Morningstar fair value estimate: $86. Monday price quote: $68.70.Data, Banks, Bond Trading 6. S&P Global (SPGI) - Get Free Report, a financial data provider Morningstar fair value estimate: $375. Monday price quote: $367.95. 7. Toronto-Dominion (TD) - Get Free Report, a Canadian bank Morningstar fair value estimate: $69. Monday price quote: $59.65. 8. Tradeweb Markets (TW) - Get Free Report, a bond trading platform Morningstar fair value estimate: $84. Monday price quote: $84.05 9. U.S. Bancorp (USB) - Get Free Report, the countryβs largest regional bank Morningstar fair value estimate: $52. Monday price quote: $32.45. 10. Visa (V) - Get Free Report, the credit card company Morningstar fair value estimate: $241. Monday price quote: $239.90. The author of this story owns shares of Berkshire Hathaway, CME, JPMorgan and U.S. Bancorp.
[Read more...](https://www.thestreet.com/stocks/financial-stocks-have-slumped-here-are-10-with-potential)
The S&P 500 Financials stock index produced a negative 3.11% return so far this year through Friday, compared with a 13% gain for the S&P 500 as a whole. But 17 financial services stocks made Morningstarβs list of the best stocks to own for 2023. The companies on that list all have wide Morningstar moat ratings. That means the firm sees them having competitive advantages that will last at least 20 years. Morningstar also says the companies have strong management teams, balance sheets and investments. Here are 10 of the companies on the financial services roster, listed alphabetically.Credit Cards, Investments, Financial Exchange 1. American Express (AXP) - Get Free Report, the upscale credit card company Morningstar fair value estimate: $178. Monday price quote: $153.05. βThe companyβs greatest strength remains its cardholder base of high-spending individuals and small businesses,β wrote Morningstar analyst Michael Miller. βThe high average spending rate on American Express cards makes its cardholders attractive to merchants, and the company has been able to form valuable partnerships in exchange for access to these cardholders.β Miller sees this trend continuing.Related: Morningstar just named 3 top 'dividend aristocrat' stocks 2. Berkshire Hathaway (BRK.B) - Get Free Report, Warren Buffettβs investment group Morningstar fair value estimate: $400. Monday price quote: $347.15. βBerkshire, owing to its diversification and its lower overall risk profile, offers one of the better risk-adjusted return profiles in the financial-services sector,β wrote Morningstar analyst Greggory Warren. βAnd it remains a generally solid candidate for downside protection during market selloffs.β In addition, βit will take some time before the firm finally succumbs to the impediments created by the sheer size and scale of its operations,β he said. Warren Buffett's Berkshire Hathaway investment group is on Morningstar's list of best financial-services stocks. shutterstock 3. CME (CME) - Get Free Report, the financial-exchange operator Morningstar fair value estimate: $215. Monday price quote: $219.25. βCME has a dominant position in many of the contracts that trade in its exchange and is well diversified across multiple product lines,β Miller wrote. βIn the long term, we anticipate that the company will continue to benefit from secular growth in the need to hedge commodity, energy, and interest rate exposure. CME also has a history of generating incremental growth through the introduction of new futures contracts.β 4. JPMorgan Chase (JPM) - Get Free Report, the financial-services group Morningstar fair value estimate: $153. Monday price quote: $147.55. 5. Northern Trust (NTRS) - Get Free Report, a trust bank Morningstar fair value estimate: $86. Monday price quote: $68.70.Data, Banks, Bond Trading 6. S&P Global (SPGI) - Get Free Report, a financial data provider Morningstar fair value estimate: $375. Monday price quote: $367.95. 7. Toronto-Dominion (TD) - Get Free Report, a Canadian bank Morningstar fair value estimate: $69. Monday price quote: $59.65. 8. Tradeweb Markets (TW) - Get Free Report, a bond trading platform Morningstar fair value estimate: $84. Monday price quote: $84.05 9. U.S. Bancorp (USB) - Get Free Report, the countryβs largest regional bank Morningstar fair value estimate: $52. Monday price quote: $32.45. 10. Visa (V) - Get Free Report, the credit card company Morningstar fair value estimate: $241. Monday price quote: $239.90. The author of this story owns shares of Berkshire Hathaway, CME, JPMorgan and U.S. Bancorp.
[Read more...](https://www.thestreet.com/stocks/financial-stocks-have-slumped-here-are-10-with-potential)
TheStreet
Financial stocks have slumped; here are 10 with potential
The S&P 500 Financials stock index posted a negative return of 3.11% year to date through Friday.
Financial stocks have slumped; here are 10 with potential
The S&P 500 Financials stock index produced a negative 3.11% return so far this year through Friday, compared with a 13% gain for the S&P 500 as a whole. But 17 financial services stocks made Morningstarβs list of the best stocks to own for 2023. The companies on that list all have wide Morningstar moat ratings. That means the firm sees them having competitive advantages that will last at least 20 years. Morningstar also says the companies have strong management teams, balance sheets and investments. Here are 10 of the companies on the financial services roster, listed alphabetically.Credit Cards, Investments, Financial Exchange 1. American Express (AXP) - Get Free Report, the upscale credit card company Morningstar fair value estimate: $178. Monday price quote: $153.05. βThe companyβs greatest strength remains its cardholder base of high-spending individuals and small businesses,β wrote Morningstar analyst Michael Miller. βThe high average spending rate on American Express cards makes its cardholders attractive to merchants, and the company has been able to form valuable partnerships in exchange for access to these cardholders.β Miller sees this trend continuing.Related: Morningstar just named 3 top 'dividend aristocrat' stocks 2. Berkshire Hathaway (BRK.B) - Get Free Report, Warren Buffettβs investment group Morningstar fair value estimate: $400. Monday price quote: $347.15. βBerkshire, owing to its diversification and its lower overall risk profile, offers one of the better risk-adjusted return profiles in the financial-services sector,β wrote Morningstar analyst Greggory Warren. βAnd it remains a generally solid candidate for downside protection during market selloffs.β In addition, βit will take some time before the firm finally succumbs to the impediments created by the sheer size and scale of its operations,β he said. Warren Buffett's Berkshire Hathaway investment group is on Morningstar's list of best financial-services stocks. shutterstock 3. CME (CME) - Get Free Report, the financial-exchange operator Morningstar fair value estimate: $215. Monday price quote: $219.25. βCME has a dominant position in many of the contracts that trade in its exchange and is well diversified across multiple product lines,β Miller wrote. βIn the long term, we anticipate that the company will continue to benefit from secular growth in the need to hedge commodity, energy, and interest rate exposure. CME also has a history of generating incremental growth through the introduction of new futures contracts.β 4. JPMorgan Chase (JPM) - Get Free Report, the financial-services group Morningstar fair value estimate: $153. Monday price quote: $147.55. 5. Northern Trust (NTRS) - Get Free Report, a trust bank Morningstar fair value estimate: $86. Monday price quote: $68.70.Data, Banks, Bond Trading 6. S&P Global (SPGI) - Get Free Report, a financial data provider Morningstar fair value estimate: $375. Monday price quote: $367.95. 7. Toronto-Dominion (TD) - Get Free Report, a Canadian bank Morningstar fair value estimate: $69. Monday price quote: $59.65. 8. Tradeweb Markets (TW) - Get Free Report, a bond trading platform Morningstar fair value estimate: $84. Monday price quote: $84.05 9. U.S. Bancorp (USB) - Get Free Report, the countryβs largest regional bank Morningstar fair value estimate: $52. Monday price quote: $32.45. 10. Visa (V) - Get Free Report, the credit card company Morningstar fair value estimate: $241. Monday price quote: $239.90. The author of this story owns shares of Berkshire Hathaway, CME, JPMorgan and U.S. Bancorp.
Read more...
The S&P 500 Financials stock index produced a negative 3.11% return so far this year through Friday, compared with a 13% gain for the S&P 500 as a whole. But 17 financial services stocks made Morningstarβs list of the best stocks to own for 2023. The companies on that list all have wide Morningstar moat ratings. That means the firm sees them having competitive advantages that will last at least 20 years. Morningstar also says the companies have strong management teams, balance sheets and investments. Here are 10 of the companies on the financial services roster, listed alphabetically.Credit Cards, Investments, Financial Exchange 1. American Express (AXP) - Get Free Report, the upscale credit card company Morningstar fair value estimate: $178. Monday price quote: $153.05. βThe companyβs greatest strength remains its cardholder base of high-spending individuals and small businesses,β wrote Morningstar analyst Michael Miller. βThe high average spending rate on American Express cards makes its cardholders attractive to merchants, and the company has been able to form valuable partnerships in exchange for access to these cardholders.β Miller sees this trend continuing.Related: Morningstar just named 3 top 'dividend aristocrat' stocks 2. Berkshire Hathaway (BRK.B) - Get Free Report, Warren Buffettβs investment group Morningstar fair value estimate: $400. Monday price quote: $347.15. βBerkshire, owing to its diversification and its lower overall risk profile, offers one of the better risk-adjusted return profiles in the financial-services sector,β wrote Morningstar analyst Greggory Warren. βAnd it remains a generally solid candidate for downside protection during market selloffs.β In addition, βit will take some time before the firm finally succumbs to the impediments created by the sheer size and scale of its operations,β he said. Warren Buffett's Berkshire Hathaway investment group is on Morningstar's list of best financial-services stocks. shutterstock 3. CME (CME) - Get Free Report, the financial-exchange operator Morningstar fair value estimate: $215. Monday price quote: $219.25. βCME has a dominant position in many of the contracts that trade in its exchange and is well diversified across multiple product lines,β Miller wrote. βIn the long term, we anticipate that the company will continue to benefit from secular growth in the need to hedge commodity, energy, and interest rate exposure. CME also has a history of generating incremental growth through the introduction of new futures contracts.β 4. JPMorgan Chase (JPM) - Get Free Report, the financial-services group Morningstar fair value estimate: $153. Monday price quote: $147.55. 5. Northern Trust (NTRS) - Get Free Report, a trust bank Morningstar fair value estimate: $86. Monday price quote: $68.70.Data, Banks, Bond Trading 6. S&P Global (SPGI) - Get Free Report, a financial data provider Morningstar fair value estimate: $375. Monday price quote: $367.95. 7. Toronto-Dominion (TD) - Get Free Report, a Canadian bank Morningstar fair value estimate: $69. Monday price quote: $59.65. 8. Tradeweb Markets (TW) - Get Free Report, a bond trading platform Morningstar fair value estimate: $84. Monday price quote: $84.05 9. U.S. Bancorp (USB) - Get Free Report, the countryβs largest regional bank Morningstar fair value estimate: $52. Monday price quote: $32.45. 10. Visa (V) - Get Free Report, the credit card company Morningstar fair value estimate: $241. Monday price quote: $239.90. The author of this story owns shares of Berkshire Hathaway, CME, JPMorgan and U.S. Bancorp.
Read more...
TheStreet
Financial stocks have slumped; here are 10 with potential
The S&P 500 Financials stock index posted a negative return of 3.11% year to date through Friday.
*ΠΠ°ΡΠΈΠΎΠ½Π°Π»ΡΠ½Π°Ρ*
via forma full 5 https://ift.tt/l0oX2sI Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3572313.html)
via forma full 5 https://ift.tt/l0oX2sI Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3572313.html)
Forma-Odezhda
ΠΠ°ΡΠΈΠΎΠ½Π°Π»ΡΠ½Π°Ρ Π³Π²Π°ΡΠ΄ΠΈΡ Π Π€ (Π ΠΎΡΠ³Π²Π°ΡΠ΄ΠΈΡ)
Π£Π·Π½Π°ΠΉΡΠ΅ ΠΎ ΠΠ°ΡΠΈΠΎΠ½Π°Π»ΡΠ½Π°Ρ Π³Π²Π°ΡΠ΄ΠΈΡ Π Π€ (Π ΠΎΡΠ³Π²Π°ΡΠ΄ΠΈΡ) Π² ΡΠ½ΡΠΈΠΊΠ»ΠΎΠΏΠ΅Π΄ΠΈΠΈ ΠΌΠ°Π³Π°Π·ΠΈΠ½Π° Π€ΠΎΡΠΌΠ° ΠΎΠ΄Π΅ΠΆΠ΄Ρ.
ΠΠ°ΡΠΈΠΎΠ½Π°Π»ΡΠ½Π°Ρ
via forma full 5 https://ift.tt/l0oX2sI Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
via forma full 5 https://ift.tt/l0oX2sI Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
Forma-Odezhda
ΠΠ°ΡΠΈΠΎΠ½Π°Π»ΡΠ½Π°Ρ Π³Π²Π°ΡΠ΄ΠΈΡ Π Π€ (Π ΠΎΡΠ³Π²Π°ΡΠ΄ΠΈΡ)
Π£Π·Π½Π°ΠΉΡΠ΅ ΠΎ ΠΠ°ΡΠΈΠΎΠ½Π°Π»ΡΠ½Π°Ρ Π³Π²Π°ΡΠ΄ΠΈΡ Π Π€ (Π ΠΎΡΠ³Π²Π°ΡΠ΄ΠΈΡ) Π² ΡΠ½ΡΠΈΠΊΠ»ΠΎΠΏΠ΅Π΄ΠΈΠΈ ΠΌΠ°Π³Π°Π·ΠΈΠ½Π° Π€ΠΎΡΠΌΠ° ΠΎΠ΄Π΅ΠΆΠ΄Ρ.
*Johnson & Johnson earnings top forecasts, shares jump, on new cancer drug boost*
Updated at 6:58 am EDT Johnson & Johnson (JNJ) - Get Free Report posted stronger-than-expected third quarter earnings Tuesday, while boosting its full-year profit forecast, thanks in part to solid gains for its new cancer treatments. Johnson & Johnson said adjusted earnings for the three months ending in September were pegged at $2.66 per share, up 4.3% from the same period last year and firmly ahead of the Street consensus forecast of $2.52 per share. Group revenues, Johnson & Johnson said, nudged 1.5% higher to $21.35 billion, a figure that also topped analysts' estimates of a $21.04 billion tally. Pharmaceuticals sales were up 5.1% to $13.9 billion while Medtech sales jumped 10% to $7.46 billion. Consumer health sales were spun-off to Kenvue, the group's stand-alone entity, earlier this year. Johnson & Johnson also lifted its 2023 earnings forecast by around 5 cents per share, talking the mid-point to around $10.10 per share, with operational sales expected between $83.6 billion and $84 billion. The new figures exclude the impact of Kenvue. βJohnson & Johnson delivered strong results and significant pipeline advances in the third quarter, providing a solid foundation for future sustained growth,β said CEO Joaquin Duato. βWith a sharpened focus on Innovative Medicine and MedTech solutions, Johnson & Johnson is innovating across the spectrum of healthcare and is poised to deliver the medical breakthroughs of tomorrow.β Johnson & Johnson shares were marked 1.02% higher in pre-market trading immediately following the earnings release to indicate an opening bell price of $159.14 each, a move that nudges the stock into positive territory for the past six months.Action Alerts PLUS offers expert portfolio guidance to help you make informed investing decisions. Sign up now.
[Read more...](https://www.thestreet.com/investing/stocks/johnson-johnson-earnings-top-forecasts-shares-jump-on-cancer-drug-boost)
Updated at 6:58 am EDT Johnson & Johnson (JNJ) - Get Free Report posted stronger-than-expected third quarter earnings Tuesday, while boosting its full-year profit forecast, thanks in part to solid gains for its new cancer treatments. Johnson & Johnson said adjusted earnings for the three months ending in September were pegged at $2.66 per share, up 4.3% from the same period last year and firmly ahead of the Street consensus forecast of $2.52 per share. Group revenues, Johnson & Johnson said, nudged 1.5% higher to $21.35 billion, a figure that also topped analysts' estimates of a $21.04 billion tally. Pharmaceuticals sales were up 5.1% to $13.9 billion while Medtech sales jumped 10% to $7.46 billion. Consumer health sales were spun-off to Kenvue, the group's stand-alone entity, earlier this year. Johnson & Johnson also lifted its 2023 earnings forecast by around 5 cents per share, talking the mid-point to around $10.10 per share, with operational sales expected between $83.6 billion and $84 billion. The new figures exclude the impact of Kenvue. βJohnson & Johnson delivered strong results and significant pipeline advances in the third quarter, providing a solid foundation for future sustained growth,β said CEO Joaquin Duato. βWith a sharpened focus on Innovative Medicine and MedTech solutions, Johnson & Johnson is innovating across the spectrum of healthcare and is poised to deliver the medical breakthroughs of tomorrow.β Johnson & Johnson shares were marked 1.02% higher in pre-market trading immediately following the earnings release to indicate an opening bell price of $159.14 each, a move that nudges the stock into positive territory for the past six months.Action Alerts PLUS offers expert portfolio guidance to help you make informed investing decisions. Sign up now.
[Read more...](https://www.thestreet.com/investing/stocks/johnson-johnson-earnings-top-forecasts-shares-jump-on-cancer-drug-boost)
TheStreet
Johnson & Johnson earnings top forecasts, shares jump, on new cancer drug boost
Johnson & Johnson's newly-structured business, which no longer includes a consumer healthcare unit, is seeing solid demand for its new cancer-focused treatments Carvykti and Tecvayli.
Johnson & Johnson earnings top forecasts, shares jump, on new cancer drug boost
Updated at 6:58 am EDT Johnson & Johnson (JNJ) - Get Free Report posted stronger-than-expected third quarter earnings Tuesday, while boosting its full-year profit forecast, thanks in part to solid gains for its new cancer treatments. Johnson & Johnson said adjusted earnings for the three months ending in September were pegged at $2.66 per share, up 4.3% from the same period last year and firmly ahead of the Street consensus forecast of $2.52 per share. Group revenues, Johnson & Johnson said, nudged 1.5% higher to $21.35 billion, a figure that also topped analysts' estimates of a $21.04 billion tally. Pharmaceuticals sales were up 5.1% to $13.9 billion while Medtech sales jumped 10% to $7.46 billion. Consumer health sales were spun-off to Kenvue, the group's stand-alone entity, earlier this year. Johnson & Johnson also lifted its 2023 earnings forecast by around 5 cents per share, talking the mid-point to around $10.10 per share, with operational sales expected between $83.6 billion and $84 billion. The new figures exclude the impact of Kenvue. βJohnson & Johnson delivered strong results and significant pipeline advances in the third quarter, providing a solid foundation for future sustained growth,β said CEO Joaquin Duato. βWith a sharpened focus on Innovative Medicine and MedTech solutions, Johnson & Johnson is innovating across the spectrum of healthcare and is poised to deliver the medical breakthroughs of tomorrow.β Johnson & Johnson shares were marked 1.02% higher in pre-market trading immediately following the earnings release to indicate an opening bell price of $159.14 each, a move that nudges the stock into positive territory for the past six months.Action Alerts PLUS offers expert portfolio guidance to help you make informed investing decisions. Sign up now.
Read more...
Updated at 6:58 am EDT Johnson & Johnson (JNJ) - Get Free Report posted stronger-than-expected third quarter earnings Tuesday, while boosting its full-year profit forecast, thanks in part to solid gains for its new cancer treatments. Johnson & Johnson said adjusted earnings for the three months ending in September were pegged at $2.66 per share, up 4.3% from the same period last year and firmly ahead of the Street consensus forecast of $2.52 per share. Group revenues, Johnson & Johnson said, nudged 1.5% higher to $21.35 billion, a figure that also topped analysts' estimates of a $21.04 billion tally. Pharmaceuticals sales were up 5.1% to $13.9 billion while Medtech sales jumped 10% to $7.46 billion. Consumer health sales were spun-off to Kenvue, the group's stand-alone entity, earlier this year. Johnson & Johnson also lifted its 2023 earnings forecast by around 5 cents per share, talking the mid-point to around $10.10 per share, with operational sales expected between $83.6 billion and $84 billion. The new figures exclude the impact of Kenvue. βJohnson & Johnson delivered strong results and significant pipeline advances in the third quarter, providing a solid foundation for future sustained growth,β said CEO Joaquin Duato. βWith a sharpened focus on Innovative Medicine and MedTech solutions, Johnson & Johnson is innovating across the spectrum of healthcare and is poised to deliver the medical breakthroughs of tomorrow.β Johnson & Johnson shares were marked 1.02% higher in pre-market trading immediately following the earnings release to indicate an opening bell price of $159.14 each, a move that nudges the stock into positive territory for the past six months.Action Alerts PLUS offers expert portfolio guidance to help you make informed investing decisions. Sign up now.
Read more...
TheStreet
Johnson & Johnson earnings top forecasts, shares jump, on new cancer drug boost
Johnson & Johnson's newly-structured business, which no longer includes a consumer healthcare unit, is seeing solid demand for its new cancer-focused treatments Carvykti and Tecvayli.
*Stocks edge lower, retail sales on deck, Goldman Sachs, United Airlines, Johnson & Johnson earnings - 5 Things To Know*
Five things you need to know before the market opens on Monday October 17:1. -- Stock Market Today: Stocks slip lower with earnings, Biden Israel visit in focus An uneasy calm in Israel's war with Hamas has investors in a cautious mood Tuesday ahead of key retail sales data and a host of third quarter earnings.2. -- Retail sales data offers health-check on consumer, inflation pressures as economy defies recession calls Gas prices may lift overall retail sales totals, but economists will be watching spending trends in core items to assess the health of the U.S. consumer heading into the autumn months..3. -- Goldman Sachs earnings on deck as CEO David Solomon feels pressure to boost profits Under fire to produce bigger profits, Goldman CEO David Solomon is sharpening the banks focus and deal-making and wealth management while exiting consumer-facing businesses..4. -- United Airlines earnings in focus as Delta sees more travel demand, higher fuel costs Record summer travel figures are likely to boost profits for United Airlines, but surging fuel costs could clip it bottom line heading into the final months of the year..5. -- Johnson & Johnson earnings top forecasts, shares jump, on new cancer drug boost Johnson & Johnson's newly-structured business, which no longer includes a consumer healthcare unit, is seeing solid demand for its new cancer-focused treatments Carvykti and Tecvayli.
[Read more...](https://www.thestreet.com/investing/stocks/stocks-lower-retail-sales-goldman-sachs-united-airlines-johnson-johnson)
Five things you need to know before the market opens on Monday October 17:1. -- Stock Market Today: Stocks slip lower with earnings, Biden Israel visit in focus An uneasy calm in Israel's war with Hamas has investors in a cautious mood Tuesday ahead of key retail sales data and a host of third quarter earnings.2. -- Retail sales data offers health-check on consumer, inflation pressures as economy defies recession calls Gas prices may lift overall retail sales totals, but economists will be watching spending trends in core items to assess the health of the U.S. consumer heading into the autumn months..3. -- Goldman Sachs earnings on deck as CEO David Solomon feels pressure to boost profits Under fire to produce bigger profits, Goldman CEO David Solomon is sharpening the banks focus and deal-making and wealth management while exiting consumer-facing businesses..4. -- United Airlines earnings in focus as Delta sees more travel demand, higher fuel costs Record summer travel figures are likely to boost profits for United Airlines, but surging fuel costs could clip it bottom line heading into the final months of the year..5. -- Johnson & Johnson earnings top forecasts, shares jump, on new cancer drug boost Johnson & Johnson's newly-structured business, which no longer includes a consumer healthcare unit, is seeing solid demand for its new cancer-focused treatments Carvykti and Tecvayli.
[Read more...](https://www.thestreet.com/investing/stocks/stocks-lower-retail-sales-goldman-sachs-united-airlines-johnson-johnson)
TheStreet
Stocks edge lower, retail sales on deck, Goldman Sachs, United Airlines, Johnson & Johnson earnings - 5 Things To Know
Stocks lower, retail sales, Goldman Sachs, United Airlines, Johnson & Johnson
Stocks edge lower, retail sales on deck, Goldman Sachs, United Airlines, Johnson & Johnson earnings - 5 Things To Know
Five things you need to know before the market opens on Monday October 17:1. -- Stock Market Today: Stocks slip lower with earnings, Biden Israel visit in focus An uneasy calm in Israel's war with Hamas has investors in a cautious mood Tuesday ahead of key retail sales data and a host of third quarter earnings.2. -- Retail sales data offers health-check on consumer, inflation pressures as economy defies recession calls Gas prices may lift overall retail sales totals, but economists will be watching spending trends in core items to assess the health of the U.S. consumer heading into the autumn months..3. -- Goldman Sachs earnings on deck as CEO David Solomon feels pressure to boost profits Under fire to produce bigger profits, Goldman CEO David Solomon is sharpening the banks focus and deal-making and wealth management while exiting consumer-facing businesses..4. -- United Airlines earnings in focus as Delta sees more travel demand, higher fuel costs Record summer travel figures are likely to boost profits for United Airlines, but surging fuel costs could clip it bottom line heading into the final months of the year..5. -- Johnson & Johnson earnings top forecasts, shares jump, on new cancer drug boost Johnson & Johnson's newly-structured business, which no longer includes a consumer healthcare unit, is seeing solid demand for its new cancer-focused treatments Carvykti and Tecvayli.
Read more...
Five things you need to know before the market opens on Monday October 17:1. -- Stock Market Today: Stocks slip lower with earnings, Biden Israel visit in focus An uneasy calm in Israel's war with Hamas has investors in a cautious mood Tuesday ahead of key retail sales data and a host of third quarter earnings.2. -- Retail sales data offers health-check on consumer, inflation pressures as economy defies recession calls Gas prices may lift overall retail sales totals, but economists will be watching spending trends in core items to assess the health of the U.S. consumer heading into the autumn months..3. -- Goldman Sachs earnings on deck as CEO David Solomon feels pressure to boost profits Under fire to produce bigger profits, Goldman CEO David Solomon is sharpening the banks focus and deal-making and wealth management while exiting consumer-facing businesses..4. -- United Airlines earnings in focus as Delta sees more travel demand, higher fuel costs Record summer travel figures are likely to boost profits for United Airlines, but surging fuel costs could clip it bottom line heading into the final months of the year..5. -- Johnson & Johnson earnings top forecasts, shares jump, on new cancer drug boost Johnson & Johnson's newly-structured business, which no longer includes a consumer healthcare unit, is seeing solid demand for its new cancer-focused treatments Carvykti and Tecvayli.
Read more...
TheStreet
Stocks edge lower, retail sales on deck, Goldman Sachs, United Airlines, Johnson & Johnson earnings - 5 Things To Know
Stocks lower, retail sales, Goldman Sachs, United Airlines, Johnson & Johnson
*ΠΠ²Π°Π½ΠΈΡ Π² Π°ΡΠΌΠΈΠΈ Π‘Π‘Π‘Π *
via forma full 5 https://ift.tt/LObds7x Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3572590.html)
via forma full 5 https://ift.tt/LObds7x Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3572590.html)
Forma-Odezhda
ΠΠ²Π°Π½ΠΈΡ Π² Π°ΡΠΌΠΈΠΈ Π‘Π‘Π‘Π
Π£Π·Π½Π°ΠΉΡΠ΅ ΠΎ ΠΠ²Π°Π½ΠΈΡ Π² Π°ΡΠΌΠΈΠΈ Π‘Π‘Π‘Π Π² ΡΠ½ΡΠΈΠΊΠ»ΠΎΠΏΠ΅Π΄ΠΈΠΈ ΠΌΠ°Π³Π°Π·ΠΈΠ½Π° Π€ΠΎΡΠΌΠ° ΠΎΠ΄Π΅ΠΆΠ΄Ρ.
ΠΠ²Π°Π½ΠΈΡ Π² Π°ΡΠΌΠΈΠΈ Π‘Π‘Π‘Π
via forma full 5 https://ift.tt/LObds7x Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
via forma full 5 https://ift.tt/LObds7x Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
Forma-Odezhda
ΠΠ²Π°Π½ΠΈΡ Π² Π°ΡΠΌΠΈΠΈ Π‘Π‘Π‘Π
Π£Π·Π½Π°ΠΉΡΠ΅ ΠΎ ΠΠ²Π°Π½ΠΈΡ Π² Π°ΡΠΌΠΈΠΈ Π‘Π‘Π‘Π Π² ΡΠ½ΡΠΈΠΊΠ»ΠΎΠΏΠ΅Π΄ΠΈΠΈ ΠΌΠ°Π³Π°Π·ΠΈΠ½Π° Π€ΠΎΡΠΌΠ° ΠΎΠ΄Π΅ΠΆΠ΄Ρ.
*Β«ΠΠΠΎΠ½ΡΠ°ΠΊΡΠ΅Β» ΠΏΠ΅ΡΠ΅Ρ
ΠΎΠ΄ΠΈΡ Π½Π° Π±Π΅ΡΠΏΠ°ΡΠΎΠ»ΡΠ½ΡΡ Π°Π²ΡΠΎΡΠΈΠ·Π°ΡΠΈΡ*
ΠΠ°ΡΠΈΠ°Π½ΡΠΎΠ² Π½Π° Π·Π°ΠΌΠ΅Π½Ρ ΠΏΠ°ΡΠΎΠ»Ρ Π½Π΅ΡΠΊΠΎΠ»ΡΠΊΠΎ β Π²ΡΠ±ΠΈΡΠ°ΠΉΡΠ΅ ΡΠ²ΠΎΠΉ.
[Read more...](https://lifehacker.ru/vkontakte-perexodit-na-besparolnuyu-avtorizaciyu/)
ΠΠ°ΡΠΈΠ°Π½ΡΠΎΠ² Π½Π° Π·Π°ΠΌΠ΅Π½Ρ ΠΏΠ°ΡΠΎΠ»Ρ Π½Π΅ΡΠΊΠΎΠ»ΡΠΊΠΎ β Π²ΡΠ±ΠΈΡΠ°ΠΉΡΠ΅ ΡΠ²ΠΎΠΉ.
[Read more...](https://lifehacker.ru/vkontakte-perexodit-na-besparolnuyu-avtorizaciyu/)
*ΠΠ°ΠΊ ΠΏΠΎΠ΄Π³ΠΎΡΠΎΠ²ΠΈΡΡ ΡΠΌΠΎΡΠΎΠ΄ΠΈΠ½Ρ ΠΊ Π·ΠΈΠΌΠ΅*
ΠΡΠΎΡΠ²ΠΈΡΠ΅ Π½Π΅ΠΌΠ½ΠΎΠ³ΠΎ Π·Π°Π±ΠΎΡΡ ΠΎΡΠ΅Π½ΡΡ, ΡΡΠΎΠ±Ρ ΠΏΠΎΠ»ΡΡΠΈΡΡ ΠΌΠ½ΠΎΠ³ΠΎ ΠΊΡΡΠΏΠ½ΡΡ ΡΠ³ΠΎΠ΄ ΡΠ»Π΅Π΄ΡΡΡΠΈΠΌ Π»Π΅ΡΠΎΠΌ.
[Read more...](https://lifehacker.ru/kak-podgotovit-smorodinu-k-zime/)
ΠΡΠΎΡΠ²ΠΈΡΠ΅ Π½Π΅ΠΌΠ½ΠΎΠ³ΠΎ Π·Π°Π±ΠΎΡΡ ΠΎΡΠ΅Π½ΡΡ, ΡΡΠΎΠ±Ρ ΠΏΠΎΠ»ΡΡΠΈΡΡ ΠΌΠ½ΠΎΠ³ΠΎ ΠΊΡΡΠΏΠ½ΡΡ ΡΠ³ΠΎΠ΄ ΡΠ»Π΅Π΄ΡΡΡΠΈΠΌ Π»Π΅ΡΠΎΠΌ.
[Read more...](https://lifehacker.ru/kak-podgotovit-smorodinu-k-zime/)
*ΠΠΎΠΌΠΏΠΎΠ·ΠΈΡΠ½ΡΠΉ*
via forma full 5 https://ift.tt/edc1Oom Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3569774.html)
via forma full 5 https://ift.tt/edc1Oom Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3569774.html)
Forma-Odezhda
ΠΠΎΠΌΠΏΠΎΠ·ΠΈΡΠ½ΡΠΉ ΠΏΠΎΠ΄Π½ΠΎΡΠΎΠΊ
Π£Π·Π½Π°ΠΉΡΠ΅ ΠΎ ΠΠΎΠΌΠΏΠΎΠ·ΠΈΡΠ½ΡΠΉ ΠΏΠΎΠ΄Π½ΠΎΡΠΎΠΊ Π² ΡΠ½ΡΠΈΠΊΠ»ΠΎΠΏΠ΅Π΄ΠΈΠΈ ΠΌΠ°Π³Π°Π·ΠΈΠ½Π° Π€ΠΎΡΠΌΠ° ΠΎΠ΄Π΅ΠΆΠ΄Ρ.
ΠΠΎΠΌΠΏΠΎΠ·ΠΈΡΠ½ΡΠΉ
via forma full 5 https://ift.tt/edc1Oom Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
via forma full 5 https://ift.tt/edc1Oom Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
Forma-Odezhda
ΠΠΎΠΌΠΏΠΎΠ·ΠΈΡΠ½ΡΠΉ ΠΏΠΎΠ΄Π½ΠΎΡΠΎΠΊ
Π£Π·Π½Π°ΠΉΡΠ΅ ΠΎ ΠΠΎΠΌΠΏΠΎΠ·ΠΈΡΠ½ΡΠΉ ΠΏΠΎΠ΄Π½ΠΎΡΠΎΠΊ Π² ΡΠ½ΡΠΈΠΊΠ»ΠΎΠΏΠ΅Π΄ΠΈΠΈ ΠΌΠ°Π³Π°Π·ΠΈΠ½Π° Π€ΠΎΡΠΌΠ° ΠΎΠ΄Π΅ΠΆΠ΄Ρ.
*Π ΠΠ°ΡΠΎΠΊΠΊΠΎ ΠΈΡΠΏΡΡΠ°Π»ΠΈ ΠΏΠ΅ΡΠ²ΡΠΉ Π² ΠΌΠΈΡΠ΅ Π²Π½Π΅Π΄ΠΎΡΠΎΠΆΠ½ΠΈΠΊ Π½Π° ΡΠΎΠ»Π½Π΅ΡΠ½ΠΎΠΉ ΡΠ½Π΅ΡΠ³ΠΈΠΈ. ΠΠ³ΠΎ ΡΠΎΠ·Π΄Π°Π»ΠΈ ΡΡΡΠ΄Π΅Π½ΡΡ*
Π ΠΏΠ°ΡΠΌΡΡΠ½ΡΠ΅ Π΄Π½ΠΈ ΠΎΠ½ ΡΠΎΠΆΠ΅ ΡΠ°Π±ΠΎΡΠ°Π΅Ρ.
[Read more...](https://lifehacker.ru/ispytaniya-avtomobilya-na-solnechnoj-energii/)
Π ΠΏΠ°ΡΠΌΡΡΠ½ΡΠ΅ Π΄Π½ΠΈ ΠΎΠ½ ΡΠΎΠΆΠ΅ ΡΠ°Π±ΠΎΡΠ°Π΅Ρ.
[Read more...](https://lifehacker.ru/ispytaniya-avtomobilya-na-solnechnoj-energii/)
*Cathie Wood pulls $2 million out of Tesla before Q3 earnings*
In the days and weeks leading up to Oct. 18, when electric vehicle leader Tesla (TSLA) - Get Free Report is set to report third-quarter earnings, investors and analysts have noted a range of negativity and excitement as shares of the company have jumped and tumbled. Morgan Stanley analyst Adam Jonas wrote in a note last week that investor sentiment is skewing "cautious," due largely to concerns over additional price cuts, which will continue to eat into Tesla's falling margins. If further roadblocks delay the full production and delivery of the coming Cybertruck, Jonas said, the price cuts are likely to continue. Related: Cathie Wood says one prominent tech stock is a stronger long-term bet than Nvidia The ongoing price war that Tesla seems so determined to win represents a trend that, to Wedbush analyst Dan Ives, cannot continue into 2024. Jonas projected that Tesla's gross margin for the quarter will fall to the 17.5% range, down from the 24.3% the company boasted as recently as December 2022. Other analysts have predicted that should the price cuts continue, Tesla's margins could fall below 15%. It seems that perhaps even Cathie Wood, a Tesla bull if ever there was one, is not opposed to benefiting from some upside before the likely volatility of the stock in the hours and days following its earnings report. Ark Invest's flagship Innovation ETF sold 7,759 shares of Tesla Oct. 16, worth just shy of $2 million based on Tesla's closing price of $253.92. Still, Wood is clearly eager to be in a strong position to see plenty of post-earnings lift; Tesla remains the fund's largest holding by a significant margin. Ark Innovation's 2.7 million shares, worth $682.3 million, are weighted at more than 10% of the fund. Related: Why Tesla shares are faltering heading into Q3 earnings Ark has trimmed its Tesla holdings by varying amounts over the past few weeks as Wood strives to maintain a holding that does not exceed much more than 10% of the fund. Wood said Monday that she sees incredible upside value from Tesla over the next five years. Beyond her projection that Tesla will be trading at $2,000 per share by 2027, Wood predicted that, once it can scale autonomous driving, Tesla's gross margins will jump into the "60s and 70s." Shares of Tesla, up around 106% for the year, fell slightly in pre-market trading. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/stocks/cathie-wood-pulls-2-million-out-of-stock-before-earnings)
In the days and weeks leading up to Oct. 18, when electric vehicle leader Tesla (TSLA) - Get Free Report is set to report third-quarter earnings, investors and analysts have noted a range of negativity and excitement as shares of the company have jumped and tumbled. Morgan Stanley analyst Adam Jonas wrote in a note last week that investor sentiment is skewing "cautious," due largely to concerns over additional price cuts, which will continue to eat into Tesla's falling margins. If further roadblocks delay the full production and delivery of the coming Cybertruck, Jonas said, the price cuts are likely to continue. Related: Cathie Wood says one prominent tech stock is a stronger long-term bet than Nvidia The ongoing price war that Tesla seems so determined to win represents a trend that, to Wedbush analyst Dan Ives, cannot continue into 2024. Jonas projected that Tesla's gross margin for the quarter will fall to the 17.5% range, down from the 24.3% the company boasted as recently as December 2022. Other analysts have predicted that should the price cuts continue, Tesla's margins could fall below 15%. It seems that perhaps even Cathie Wood, a Tesla bull if ever there was one, is not opposed to benefiting from some upside before the likely volatility of the stock in the hours and days following its earnings report. Ark Invest's flagship Innovation ETF sold 7,759 shares of Tesla Oct. 16, worth just shy of $2 million based on Tesla's closing price of $253.92. Still, Wood is clearly eager to be in a strong position to see plenty of post-earnings lift; Tesla remains the fund's largest holding by a significant margin. Ark Innovation's 2.7 million shares, worth $682.3 million, are weighted at more than 10% of the fund. Related: Why Tesla shares are faltering heading into Q3 earnings Ark has trimmed its Tesla holdings by varying amounts over the past few weeks as Wood strives to maintain a holding that does not exceed much more than 10% of the fund. Wood said Monday that she sees incredible upside value from Tesla over the next five years. Beyond her projection that Tesla will be trading at $2,000 per share by 2027, Wood predicted that, once it can scale autonomous driving, Tesla's gross margins will jump into the "60s and 70s." Shares of Tesla, up around 106% for the year, fell slightly in pre-market trading. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/stocks/cathie-wood-pulls-2-million-out-of-stock-before-earnings)
TheStreet
Cathie Wood pulls $2 million out of beloved stock before earnings
This tech giant is set to report third-quarter earnings Wednesday.
Cathie Wood pulls $2 million out of Tesla before Q3 earnings
In the days and weeks leading up to Oct. 18, when electric vehicle leader Tesla (TSLA) - Get Free Report is set to report third-quarter earnings, investors and analysts have noted a range of negativity and excitement as shares of the company have jumped and tumbled. Morgan Stanley analyst Adam Jonas wrote in a note last week that investor sentiment is skewing "cautious," due largely to concerns over additional price cuts, which will continue to eat into Tesla's falling margins. If further roadblocks delay the full production and delivery of the coming Cybertruck, Jonas said, the price cuts are likely to continue. Related: Cathie Wood says one prominent tech stock is a stronger long-term bet than Nvidia The ongoing price war that Tesla seems so determined to win represents a trend that, to Wedbush analyst Dan Ives, cannot continue into 2024. Jonas projected that Tesla's gross margin for the quarter will fall to the 17.5% range, down from the 24.3% the company boasted as recently as December 2022. Other analysts have predicted that should the price cuts continue, Tesla's margins could fall below 15%. It seems that perhaps even Cathie Wood, a Tesla bull if ever there was one, is not opposed to benefiting from some upside before the likely volatility of the stock in the hours and days following its earnings report. Ark Invest's flagship Innovation ETF sold 7,759 shares of Tesla Oct. 16, worth just shy of $2 million based on Tesla's closing price of $253.92. Still, Wood is clearly eager to be in a strong position to see plenty of post-earnings lift; Tesla remains the fund's largest holding by a significant margin. Ark Innovation's 2.7 million shares, worth $682.3 million, are weighted at more than 10% of the fund. Related: Why Tesla shares are faltering heading into Q3 earnings Ark has trimmed its Tesla holdings by varying amounts over the past few weeks as Wood strives to maintain a holding that does not exceed much more than 10% of the fund. Wood said Monday that she sees incredible upside value from Tesla over the next five years. Beyond her projection that Tesla will be trading at $2,000 per share by 2027, Wood predicted that, once it can scale autonomous driving, Tesla's gross margins will jump into the "60s and 70s." Shares of Tesla, up around 106% for the year, fell slightly in pre-market trading. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...
In the days and weeks leading up to Oct. 18, when electric vehicle leader Tesla (TSLA) - Get Free Report is set to report third-quarter earnings, investors and analysts have noted a range of negativity and excitement as shares of the company have jumped and tumbled. Morgan Stanley analyst Adam Jonas wrote in a note last week that investor sentiment is skewing "cautious," due largely to concerns over additional price cuts, which will continue to eat into Tesla's falling margins. If further roadblocks delay the full production and delivery of the coming Cybertruck, Jonas said, the price cuts are likely to continue. Related: Cathie Wood says one prominent tech stock is a stronger long-term bet than Nvidia The ongoing price war that Tesla seems so determined to win represents a trend that, to Wedbush analyst Dan Ives, cannot continue into 2024. Jonas projected that Tesla's gross margin for the quarter will fall to the 17.5% range, down from the 24.3% the company boasted as recently as December 2022. Other analysts have predicted that should the price cuts continue, Tesla's margins could fall below 15%. It seems that perhaps even Cathie Wood, a Tesla bull if ever there was one, is not opposed to benefiting from some upside before the likely volatility of the stock in the hours and days following its earnings report. Ark Invest's flagship Innovation ETF sold 7,759 shares of Tesla Oct. 16, worth just shy of $2 million based on Tesla's closing price of $253.92. Still, Wood is clearly eager to be in a strong position to see plenty of post-earnings lift; Tesla remains the fund's largest holding by a significant margin. Ark Innovation's 2.7 million shares, worth $682.3 million, are weighted at more than 10% of the fund. Related: Why Tesla shares are faltering heading into Q3 earnings Ark has trimmed its Tesla holdings by varying amounts over the past few weeks as Wood strives to maintain a holding that does not exceed much more than 10% of the fund. Wood said Monday that she sees incredible upside value from Tesla over the next five years. Beyond her projection that Tesla will be trading at $2,000 per share by 2027, Wood predicted that, once it can scale autonomous driving, Tesla's gross margins will jump into the "60s and 70s." Shares of Tesla, up around 106% for the year, fell slightly in pre-market trading. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...
TheStreet
Cathie Wood pulls $2 million out of beloved stock before earnings
This tech giant is set to report third-quarter earnings Wednesday.
*Π€ΠΎΡΠΌΠ° ΠΎΠ΄Π΅ΠΆΠ΄Ρ*
via forma full 5 https://ift.tt/uxCaq4w Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3571095.html)
via forma full 5 https://ift.tt/uxCaq4w Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3571095.html)
Forma-Odezhda
Π€ΠΎΡΠΌΠ° ΠΎΠ΄Π΅ΠΆΠ΄Ρ - ΠΌΠ°Π³Π°Π·ΠΈΠ½ ΡΠΎΡΠΌΠ΅Π½Π½ΠΎΠΉ ΠΎΠ΄Π΅ΠΆΠ΄Ρ ΠΏΠΎΠ»ΠΈΡΠΈΠΈ, ΠΠ§Π‘, ΠΠΠ
ΠΠΎΠ΅Π½ΡΠΎΡΠ³ Π€ΠΎΡΠΌΠ° ΠΎΠ΄Π΅ΠΆΠ΄Ρ - ΡΡΡΠ°Π²Π½Π°Ρ ΡΠΎΡΠΌΠ°, ΠΊΠ°ΠΌΡΡΠ»ΡΠΆ, Π²ΠΎΠ΅Π½Π½Π°Ρ ΠΎΠ΄Π΅ΠΆΠ΄Π°, Π²ΠΎΠ΅Π½ΡΠΎΡΠ³ΠΈ ΠΌΠΎΡΠΊΠ²Ρ, Π°ΡΠΌΠ΅ΠΉΡΠΊΠΈΠΉ ΠΌΠ°Π³Π°Π·ΠΈΠ½, Π²ΠΎΠ΅Π½Π½ΡΠΉ ΠΌΠ°Π³Π°Π·ΠΈΠ½, ΡΠΎΡΠΌΠ° ΠΏΠΎΠ»ΠΈΡΠΈΠΈ, ΡΠΎΡΠΌΠ° ΠΠ§Π‘
Π€ΠΎΡΠΌΠ° ΠΎΠ΄Π΅ΠΆΠ΄Ρ
via forma full 5 https://ift.tt/uxCaq4w Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
via forma full 5 https://ift.tt/uxCaq4w Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
Forma-Odezhda
Π€ΠΎΡΠΌΠ° ΠΎΠ΄Π΅ΠΆΠ΄Ρ - ΠΌΠ°Π³Π°Π·ΠΈΠ½ ΡΠΎΡΠΌΠ΅Π½Π½ΠΎΠΉ ΠΎΠ΄Π΅ΠΆΠ΄Ρ ΠΏΠΎΠ»ΠΈΡΠΈΠΈ, ΠΠ§Π‘, ΠΠΠ
ΠΠΎΠ΅Π½ΡΠΎΡΠ³ Π€ΠΎΡΠΌΠ° ΠΎΠ΄Π΅ΠΆΠ΄Ρ - ΡΡΡΠ°Π²Π½Π°Ρ ΡΠΎΡΠΌΠ°, ΠΊΠ°ΠΌΡΡΠ»ΡΠΆ, Π²ΠΎΠ΅Π½Π½Π°Ρ ΠΎΠ΄Π΅ΠΆΠ΄Π°, Π²ΠΎΠ΅Π½ΡΠΎΡΠ³ΠΈ ΠΌΠΎΡΠΊΠ²Ρ, Π°ΡΠΌΠ΅ΠΉΡΠΊΠΈΠΉ ΠΌΠ°Π³Π°Π·ΠΈΠ½, Π²ΠΎΠ΅Π½Π½ΡΠΉ ΠΌΠ°Π³Π°Π·ΠΈΠ½, ΡΠΎΡΠΌΠ° ΠΏΠΎΠ»ΠΈΡΠΈΠΈ, ΡΠΎΡΠΌΠ° ΠΠ§Π‘